Why Is Temozolomide So Hard to Find? [Explained for 2026]

You just received a prescription for temozolomide — also known by its brand name Temodar — and you've called three pharmacies only to be told it's not in stock. If this sounds familiar, you're not alone. Many patients and caregivers encounter real friction when trying to fill this medication, even though it is not currently on the FDA's official drug shortage list. Here's what's actually going on.

What Is Temozolomide and Who Uses It?

Temozolomide is an oral chemotherapy agent classified as an alkylating drug. It is FDA-approved for adults with newly diagnosed glioblastoma multiforme (GBM) — the most aggressive form of brain cancer — given alongside radiation therapy and then as maintenance treatment. It is also approved for adults with newly diagnosed or refractory anaplastic astrocytoma. The FDA first approved its intravenous form in 1999 and the oral capsule for GBM in 2005, and updated the labeling in September 2023 under its Project Renewal initiative.

Because temozolomide treats relatively rare and aggressive cancers, it is classified as a specialty medication. This has enormous implications for where and how it is stocked.

Why Is It Hard to Find at Regular Pharmacies?

Unlike common medications such as blood pressure pills or antibiotics, temozolomide is not kept in large quantities at every retail pharmacy. Several factors contribute to this:

• Low patient volume: GBM affects roughly 14,000 Americans per year. With such a small patient population relative to common drugs, most community pharmacies see little demand and keep little or no stock.
• Multiple capsule strengths: Temozolomide comes in 5 mg, 20 mg, 100 mg, 140 mg, 180 mg, and 250 mg capsules, and doses are calculated by body surface area. Pharmacies that do stock it may only carry certain strengths.
• Short treatment windows: Temozolomide is given in cycles — 5 days on, 23 days off — so timing is critical. A delay of even a few days in obtaining the medication can stress patients and caregivers already dealing with a serious diagnosis.
• Insurance prior authorization: Because this is a high-cost specialty drug (retail prices exceed $3,000 for a 5-day supply without coupons), most insurance plans require prior authorization before dispensing. This administrative step adds days to the fill process.

Is There Currently a Temozolomide Shortage?

As of 2026, temozolomide is not listed on the FDA's active drug shortage database. Several generic manufacturers — including Lannett, Amneal, Sun Pharma, and Camber Pharmaceuticals (which launched a new generic in May 2025) — produce the medication, providing supply redundancy. However, the absence of an FDA shortage designation does not mean every pharmacy has it on the shelf. Localized availability gaps are common with specialty oncology drugs, particularly at non-specialty pharmacies.

The Real Problem: Distribution, Not Production

Even when temozolomide is being manufactured in adequate quantities nationally, patients experience difficulty finding it locally. The disconnect happens in the distribution layer: specialty pharmacies may be located far from a patient's home, mail-order shipment may be too slow given treatment cycle timing, and retail pharmacies simply don't order it because demand is unpredictable. This means you may need to call multiple pharmacies or request a specialty pharmacy referral from your oncology team.

What Can Patients Do Right Now?

Here are practical steps patients and caregivers can take if temozolomide is hard to fill:

1. Ask your oncology team for a specialty pharmacy referral. Cancer centers typically have relationships with specialty pharmacies and can route your prescription directly.
2. Call pharmacies ahead of your treatment cycle. Don't wait until Day 1. Start calling 7–10 days before each new cycle to confirm stock and allow time for order placement.
3. Use medfinder. medfinder.com calls pharmacies near you to check which ones can fill your specific temozolomide strength and quantity — saving you hours of phone calls.
4. Verify the exact strength needed. Because doses are BSA-based, you may need multiple capsule strengths per cycle (e.g., 100 mg + 20 mg + 5 mg). Confirm exactly what your prescription calls for before calling pharmacies.
5. Consider mail-order or hospital pharmacy. Your cancer center's in-house pharmacy or a mail-order specialty pharmacy may be the most reliable sources, especially if your treatment is ongoing.

How medfinder Can Help

medfinder is designed for exactly this problem. When you need to find a specialty or hard-to-locate drug like temozolomide, medfinder.com contacts pharmacies near your location to check which ones have your medication in stock and can fill your prescription. Results are texted directly to you — no endless hold music required.

For more strategies on locating this medication, read our guide: How to Find Temozolomide in Stock Near You (Tools + Tips).

Bottom Line

Temozolomide is not in a national shortage, but its specialty drug status, BSA-based dosing across multiple strengths, and low local demand mean that many retail pharmacies simply don't stock it. The solution is to work with specialty pharmacies, communicate with your oncology team early, and use tools like medfinder to locate available stock near you before each treatment cycle begins.